Edition:
United States

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

2.05USD
15 Dec 2017
Change (% chg)

$0.10 (+5.13%)
Prev Close
$1.95
Open
$1.95
Day's High
$2.10
Day's Low
$1.95
Volume
72,143
Avg. Vol
215,740
52-wk High
$5.75
52-wk Low
$1.58

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.49 -0.281
Jun '17 2.66 -0.288
Mar '17 3.11 -0.343
FY 2016 Dec '16 6.43 -0.214
Sep '16 3.37 -0.252
Jun '16 4.53 -0.245
Mar '16 3.03 -0.242
FY 2015 Dec '15 1.73 -0.237
Sep '15 15.43 0.113
Jun '15 1.92 -0.201
Mar '15 0.18 -0.229
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 5 3.44 7.80 1.79 2.01
Quarter Ending Mar-18 2 2.76 3.63 1.90 1.50
Year Ending Dec-17 5 10.85 15.00 9.00 7.63
Year Ending Dec-18 5 14.60 30.60 6.90 43.40
Earnings (per share)
Quarter Ending Dec-17 5 -0.21 -0.18 -0.25 -0.26
Quarter Ending Mar-18 2 -0.22 -0.20 -0.24 --
Year Ending Dec-17 5 -1.08 -1.00 -1.14 -1.09
Year Ending Dec-18 5 -1.01 -0.85 -1.13 -0.55
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta 2.97 0.82 0.91
Price to Sales (TTM) 7.54 122.78 5.95
Price to Book (MRQ) -- 23.45 5.68
Price to Tangible Book (MRQ) -- 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 33.30 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -55.82 -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago 8.20 29.98 5.62
Sales - 5 Yr. Growth Rate 74.52 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -11.55 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago -15.32 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate 13.00 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.71 1.79 2.55
Current Ratio (MRQ) 4.78 5.62 3.56
LT Debt to Equity (MRQ) -- 16.22 13.38
Total Debt to Equity (MRQ) -- 18.71 19.38
Interest Coverage (TTM) -2.76 -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 6.08 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -263.83 -- --
EBITD - 5 Yr. Avg -161.51 -215.66 15.63
Operating Margin (TTM) -277.67 -642.63 6.56
Operating Margin - 5 Yr. Avg. -170.81 -232.87 11.00
Pre-Tax Margin (TTM) -374.75 -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -212.89 -233.04 11.41
Net Profit Margin (TTM) -374.76 -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -213.88 -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 351,026 22,314,532 851,801,741
Net Income/Employee (TTM) -1,315,513 -1,997,855 99,542,701
Receivable Turnover (TTM) 8.17 26.15 6.13
Inventory Turnover (TTM) 10.93 2.62 3.56
Asset Turnover (TTM) 0.15 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -54.37 -9.39 11.31
Return on Assets - 5 Yr. Avg. -34.34 0.28 12.28
Return on Investment (TTM) -64.80 -11.76 14.43
Return on Investment - 5 Yr. Avg. -39.19 3.42 16.07
Return on Equity (TTM) -- -36.72 16.01
Return on Equity - 5 Yr. Avg. -81.78 5.75 17.27
  1 Year 3 Year 5 Year
Sales % -9.89 -16.21 74.52
EPS (TTM) % -72.93 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AcelRx Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 33.26%
# of Holders: 76
Total Shares Held: 16,740,288
3 Mo. Net Change: -3,734,468
# New Positions: 16
# Closed Positions: 22
# Increased Positions: 31
# Reduced Positions: 41
# Net Buyers: -10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.